Sansure Biotech Inc. operates as an in vitro diagnostic solution provider. The Company develops and sells upstream nucleic acid extraction kits, novel coronavirus nucleic acid detection kits, and other products. Sansure Biotech markets its products worldwide.
more
Refresh
Exchange Announcement • 29 Mar 2021 18:51
Shengxiang Biotechnology Co., Ltd. Announcement on Judicial Freezing of Shares of More than 5% Shareholders (圣湘生物科技股份有限公司关于5%以上股东股份被司法冻结的公告)